This inventor holds 6 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Dermavant Sciences Gmbh. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2023
Title: Piyush Jain: Innovator in Topical Pharmaceutical Compositions
Introduction
Piyush Jain is a notable inventor based in Chester Springs, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical compositions. With a total of six patents to his name, Jain's work focuses on innovative solutions for dermatological conditions.
Latest Patents
Among his latest patents, Jain has developed topical pharmaceutical emulsion compositions that include a therapeutically effective amount of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a pharmaceutically acceptable salt thereof. These compositions consist of an oil phase, a water phase, a surfactant, and an antioxidant, ensuring that the emulsion is homogeneous and that the active ingredient is solubilized in the oil phase. The invention also outlines methods for treating dermatological conditions by administering these compositions to the skin of patients.
Career Highlights
Piyush Jain is currently associated with Dermavant Sciences GmbH, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing topical treatments that address various skin disorders.
Collaborations
Jain collaborates with talented professionals in his field, including Sujatha D Sonti and Joey Roger Thomas. Their combined expertise contributes to the success of their projects and the development of effective pharmaceutical solutions.
Conclusion
Piyush Jain's contributions to the field of topical pharmaceuticals highlight his commitment to improving patient care through innovative inventions. His work continues to pave the way for advancements in dermatological treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile